Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P23945: Variant p.Ala575Val

Follicle-stimulating hormone receptor
Gene: FSHR
Feedback?
Variant information Variant position: help 575 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Alanine (A) to Valine (V) at position 575 (A575V, p.Ala575Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In OHSS; decreases cell surface expression; no effect on hormone binding; increases levels of internalized hormone receptor complex; cAMP levels are similar to basal levels even at high doses of FSH stimulation indicating reduced signaling. Any additional useful information about the variant.


Sequence information Variant position: help 575 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 695 The length of the canonical sequence.
Location on the sequence: help TVRNPNIVSSSSDTRIAKRM A MLIFTDFLCMAPISFFAISA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         TVRNPNIVSSSSDTRIAKRMAMLIFTDFLCMAPISFFAISA

Mouse                         TVRNPNIVSSSRDTKIAKRMATLIFTDFLCMAPILFFAISA

Rat                           TVRNPTIVSSSSDTKIAKRMATLIFTDFLCMAPISFFAISA

Pig                           TVRNPNIMSSSSDTKIAKRMAMLIFTDFLCMAPISFFAISA

Bovine                        TVRNPNITSSSSDTKIAKRMAMLIFTDFLCMAPISFFAISA

Sheep                         TVRNPNITSSSSDTKIAKRMAMLIFTDFLCMAPISFFAISA

Cat                           TVRNPNIVSSSSDTKIAKRMAMLIFTDFLCMAPISFFAISA

Horse                         TVRNPNIVSSSSDTKIAKRMAILIFTDFLCMAPISFFAISA

Chicken                       TVRNPNVISSNSDTKIAKRMAILIFTDFLCMAPISFFAISA
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 18 – 695 Follicle-stimulating hormone receptor
Transmembrane 574 – 597 Helical; Name=6
Helix 564 – 596



Literature citations
Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor.
Desai S.S.; Achrekar S.K.; Sahasrabuddhe K.A.; Meharji P.K.; Desai S.K.; Mangoli V.S.; Mahale S.D.;
J. Clin. Endocrinol. Metab. 100:E638-E645(2015)
Cited for: VARIANTS OHSS ALA-514 AND VAL-575; CHARACTERIZATION OF VARIANTS OHSS ALA-514 AND VAL-575;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.